The Alethia™ Pertussis DNA amplification assay is a qualitative in vitro diagnostic test for the direct detection of Bordetella pertussis in human nasopharyngeal swab samples taken from patients suspected of having respiratory tract infection attributable to Bordetella pertussis.

• With molecular results in less than one hour, long turnaround times and send out costs can be eliminated
• Targeted detection can help physicians treat patients appropriately

The molecular accuracy of Alethia™ Pertussis provides a clear and objective evaluation of positive/negative test results. This can help to reduce the risk of spreading illness to others and allow for appropriate treatment as soon as possible.